news

SIR 2026 will feature over 10 specialized topic tracks!

Mar 12, 2026
SIR Annual Scientific Meeting
Take a look!

  1. Interventional oncology

  2. Arterial interventions and peripheral artery disease (PAD)

  3. Neurointerventional radiology

  4. Venous interventions

  5. Renal and genitourinary interventions 

  6. Women's health

  7. Nonvascular interventions (including portal hypertension)

  8. Pain management/MSK

  9. Pediatric interventions

  10. Embolization

Quick links

More news from SIR

  1. Guidewire

    CMS releases 2025 MIPS final scores and opens targeted review period

    CMS released 2025 MIPS final scores and performance feedback, which will determine Medicare payment adjustments in 2027. Learn more about reviewing scores and the targeted review period.

    Oct 15, 2026
  2. Guidewire

    Updated guidelines for adult cancer pain

    NCCN has incorporated an SIR recommendation into its 2026 Adult Cancer Pain Guidelines. View the updated guideline.

    Oct 15, 2026
    Quality improvement Interventional Oncology
  3. Guidewire

    Remember to apply for Dr. Gary J. Becker Young Investigator Award

    Applications for the Dr. Gary J. Becker Young Investigator Award are due Nov. 15 at 5 p.m. ET. Learn more and apply.

    Oct 15, 2026
    Research Funding: Awards Foundation
  4. Guidewire

    Bridging the language gap in interventional radiology

    Explore a JVIR study on the accessibility of Spanish- and English-language patient education about uterine artery embolization. Read the study.

    Oct 15, 2026
    IR research JVIR Embolization
  5. Guidewire

    VIRTEX measure supports consistent assessment of liver cancer treatment response

    VIRTEX helps IR practices consistently assess liver cancer treatment response and use outcomes data to support quality improvement.

    Oct 15, 2026
    Quality improvement Practice development VIRTEX Clinical data registries
  6. Guidewire

    New paper outlines growing role of IR in liver cancer treatment

    Read more on how IRs are playing a growing, cost-efficient role in liver cancer care, according to new JVIR research.

    Oct 15, 2026
    IR research JVIR